Mukka Proteins share price
NSE: MUKKAFMCGPackaged Foods
Mukka Proteins at a glance
Mukka Proteins (NSE: MUKKA) closed at ₹25.20 on 22 Oct 2026, down 2.33% on the day. With a market capitalisation of ₹756 Cr, it ranks 1588th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the FMCG sector; its industry is Packaged Foods.
At its last close the stock traded at 14.5× trailing earnings, against a return on equity of 10.4% in FY26. Over the past year the share price has fallen 1.4%. Its 52-week range is ₹18.27 (30 Mar 2026) to ₹33.29 (15 Sep 2026); the last close is 24.3% below the high. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹368 Cr (−1.2% year on year) and net profit ₹21 Cr (+50.7%), on a consolidated basis. Promoters held 73.33% of the company as of 30 Jun 2026.
Key numbers
- Market cap
- ₹756 CrRank 1588 on NSE
- P/E (trailing)
- 14.5×
- Price to book
- 1.11×FY26
- EPS (TTM)
- ₹1.73to Q4 FY26
- ROE
- 10.4%FY26
- ROCE
- 22.1%FY26
- Debt to equity
- 1.54FY26
- Net profit margin
- 3.8%FY26
- Book value / share
- ₹16.64FY26
- 52-week high
- ₹33.2915 Sep 2026
- 52-week low
- ₹18.2730 Mar 2026
- 1-year return
- −1.4%
- RSI (14-day)
- 39.5
Returns to 22 Oct 2026
| Period | 1 day | 1 week | 1 month | 3 months | 1 year |
|---|---|---|---|---|---|
| Price change | −2.33% | −12.5% | −10.9% | +8.2% | −1.4% |
Mukka Proteins quarterly results
| Quarter | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹167 Cr | ₹145 Cr | ₹296 Cr | ₹372 Cr | ₹171 Cr | ₹245 Cr | ₹635 Cr | ₹368 Cr |
| Revenue YoY | −40.8% | −55.3% | −41.0% | +49.0% | +2.4% | +68.9% | +114.3% | −1.2% |
| Net profit | ₹5 Cr | ₹1 Cr | ₹26 Cr | ₹14 Cr | ₹2 Cr | ₹7 Cr | ₹24 Cr | ₹21 Cr |
| Net profit YoY | −13.8% | −97.6% | +154.4% | −49.1% | −62.6% | +1,027.7% | −7.1% | +50.7% |
| Net margin | 3.3% | 0.4% | 8.9% | 3.8% | 1.2% | 3.0% | 3.8% | 5.8% |
| EPS | ₹0.14 | ₹0.07 | ₹0.88 | ₹0.45 | ₹0.05 | ₹0.20 | ₹0.79 | ₹0.69 |
Mukka Proteins financials
| Item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Revenue | ₹604 Cr | ₹771 Cr | ₹1,177 Cr | ₹1,380 Cr | ₹1,006 Cr | — |
| Operating profit | ₹12 Cr | ₹35 Cr | ₹64 Cr | ₹84 Cr | ₹59 Cr | — |
| Net profit | ₹7 Cr | ₹25 Cr | ₹46 Cr | ₹71 Cr | ₹47 Cr | — |
| EPS (₹) | ₹0.00 | ₹1.00 | ₹2.00 | ₹3.00 | ₹2.00 | — |
| Cash from operations | ₹6 Cr | ₹5 Cr | −₹54 Cr | −₹150 Cr | −₹112 Cr | — |
| Total debt | ₹17 Cr | ₹9 Cr | ₹5 Cr | ₹6 Cr | ₹3 Cr | ₹32 Cr |
| Shareholders' equity | ₹66 Cr | ₹98 Cr | ₹148 Cr | ₹396 Cr | ₹441 Cr | ₹499 Cr |
Mukka Proteins shareholding pattern
| Holder | 31 Mar 2025 | 30 Jun 2025 | 30 Sep 2025 | 31 Dec 2025 | 31 Mar 2026 | 30 Jun 2026 |
|---|---|---|---|---|---|---|
| Promoters | 73.33% | 73.33% | 73.33% | 73.33% | 73.33% | 73.33% |
| Foreign institutions | 2.63% | 2.08% | 1.70% | 1.70% | 1.70% | 1.73% |
| Non-institutions | 22.05% | 22.71% | 23.31% | 24.80% | 24.97% | 24.93% |
Mukka Proteins vs peers
The listed FMCG companies nearest to Mukka Proteins by market capitalisation.
| Company | Price | 1 day | 1 year | Market cap | P/E | ROE |
|---|---|---|---|---|---|---|
| BCLINDBcl Industries | ₹28.85 | +1.62% | −26.4% | ₹852 Cr | 7.4 | — |
| DWARKESHDwarikesh Sugar Industries | ₹45.61 | −1.49% | +4.6% | ₹845 Cr | 27.5 | — |
| VADILENTVadilal Enter | ₹9,540.00 | 0.00% | — | ₹823 Cr | 78.5 | — |
| MAGADSUGARMagadh Sugar & Energy | ₹558.55 | −0.79% | +0.6% | ₹787 Cr | 12.4 | — |
| IFBAGROIFB Agro Industries | ₹827.45 | −1.38% | −9.4% | ₹775 Cr | 13.7 | — |
| MUKKAMukka Proteins | ₹25.20 | −2.33% | −1.4% | ₹756 Cr | 14.5 | — |
| MAWANASUGMawana Sugars | ₹176.00 | −3.03% | +103.6% | ₹688 Cr | 18.6 | — |
Ask anything about Mukka Proteins
Pivot answers on the live chart with evidence you can check, and tests strategies against MUKKA's own history. Try: “Why has MUKKA moved over the last three months?” · “Backtest a 50-day moving-average crossover on MUKKA over five years” · “Compare MUKKA with BCLIND on margins and valuation”
Frequently asked questions about Mukka Proteins
What is the share price of Mukka Proteins today?
Mukka Proteins (NSE: MUKKA) last closed at ₹25.20 on 22 Oct 2026. Its 52-week high is ₹33.29 and its 52-week low is ₹18.27.
What is the market cap of Mukka Proteins?
Mukka Proteins' market capitalisation is ₹756 Cr (₹756 Cr) at the 22 Oct 2026 close, ranking 1588th among the NSE companies Pivot tracks.
What is the P/E ratio of Mukka Proteins?
Mukka Proteins trades at a trailing P/E of 14.5. The median P/E of the 6 closest FMCG peers by market cap is 18.6.
What is the ROE and ROCE of Mukka Proteins?
Return on equity was 10.4% in FY26 and return on capital employed was 22.1% in FY26 (consolidated figures).
Is Mukka Proteins a debt-free company?
No. Mukka Proteins' debt-to-equity ratio was 1.54 in FY26, with total debt of ₹32 Cr.
What were Mukka Proteins' latest quarterly results?
For Q4 FY26 (quarter ended 31 Mar 2026), Mukka Proteins reported revenue of ₹368 Cr, −1.2% year on year, and net profit of ₹21 Cr, +50.7% year on year.
How has Mukka Proteins stock performed over the last year?
Mukka Proteins' share price has fallen 1.4% over the past year, +8.2% over three months and −10.9% over one month, to the 22 Oct 2026 close.
What is the shareholding pattern of Mukka Proteins?
As of 30 Jun 2026: promoters 73.33%, foreign institutions 1.73%, non-institutions 24.93%.
Who are Mukka Proteins' competitors?
The listed FMCG companies closest to Mukka Proteins by market cap are Bcl Industries, Dwarikesh Sugar Industries, Vadilal Enter, Magadh Sugar & Energy, IFB Agro Industries and Mawana Sugars.
Is Mukka Proteins a good stock to buy?
Pivot does not give buy or sell recommendations. This page sets out Mukka Proteins' price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on MUKKA against its own history before risking money. This is analysis, not financial advice.
Sources and method
Prices: NSE daily closes to 22 Oct 2026 (returns and ratios at the 22 Oct 2026 close). Fundamentals: company filings via Moneycontrol, consolidated where available. Shareholding: exchange shareholding-pattern filings. The 52-week range uses intraday highs and lows; the chart marks closing prices. P/E is the last close over trailing twelve-month EPS. Market-cap rank is among the 4,183 NSE companies Pivot tracks; SEBI's bands call the top 100 large-cap and the next 150 mid-cap. Figures marked “—” are not available rather than zero. This is analysis, not financial advice.
More: all FMCG stocks · companies starting with M · all NSE stocks · this page as text